Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

ONE DAY left in this Mid-Year Campaign. This is our hour of need.
If you value independent journalism, please support Common Dreams.

Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Without your help, we won’t survive.

Rep. Katie Porter (D-Calif.) took Big Pharma CEOs to task for charging exorbitant prices for life-saving medications during a House Oversight Committee hearing on September 30, 2020. (Photo: Tom Williams/CQ-Roll Call, Inc. via Getty Images)

Rep. Katie Porter (D-Calif.) speaks during a House Financial Services Committee hearing on Tuesday, October 22, 2019. (Photo: Tom Williams/CQ-Roll Call, Inc. via Getty Images)

WATCH: Katie Porter, Squad Members Eviscerate Big Pharma CEOs Over 'Exorbitant' Drug Prices

"To recap here: The drug didn't get any better, the cancer patients didn't get any better, you just got better at making money—you just refined your skills at price gouging." 

Brett Wilkins

House Democrats—including three Squad members—tore into pharmaceutical industry chief executives during a Wednesday congressional hearing on Big Pharma profiteering, with Rep. Katie Porter verbally eviscerating one CEO for more than tripling the price of a critical cancer drug. 

Wednesday marked the first day of a two-day House Oversight Committee hearing titled "Unsustainable Drug Prices: Testimony from the CEOs." Bristol Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kåre Schultz, and former Celgene CEO Mark Alles all endured nearly four hours of grilling over the price of prescription drugs—which are almost always far more expensive in the United States than anywhere else in the world.

Porter (D-Calif.), a former consumer protection attorney, was the most ferocious committee member to address the CEOs. Bringing out her infamous white board, she attacked Celgene's repeated price hikes for the cancer drug Revlimid, which now costs $763 per dose—in 2005 it cost $215. When Alles attempted to explain that the drug has been approved for new uses, Porter hit back, and hard.

"Did the drug start to work faster? Were there fewer side effects? How did you change the formula or production of Revlimid to justify this price increase?" Porter asked. "To recap here: The drug didn't get any better, the cancer patients didn't get any better, you just got better at making money—you just refined your skills at price gouging."

Porter has built a reputation for speaking tough truth to power, on issues ranging from defending access to crucial public benefits, to challenging mega-bank CEOs on income inequality, to exposing the pernicious influence of dark money in politics.

Toward the end of Wednesday's nearly four-hour session, three of the four members of the so-called Squad—Reps. Rashida Tlaib (D-Mich.), Ayanna Pressley (D-Mass.), and Alexandria Ocasio-Cortez (D-N.Y.)—slammed the CEOs over what Ocasio-Cortez called the "exorbitant cost" of life-saving medications. 

Armed with a chart showing the cost of 40 milligrams of Teva's multiple sclerosis drug Copaxone is more than five times as high in the U.S. as in Britain, Ocasio-Cortez refuted an assertion by Schultz that medications cost more in the United States because American patients have "very broad, and very early access" to new drugs.

Citing Teva's own internal documents, Ocasio-Cortez showed the company was forced to lower prices by European governments—which unlike the U.S. have instituted spending controls—even as it raised prices for American patients.

Pressley asserted that "the lack of access to affordable life-saving medicine is an injustice [that] represents an act of economic violence and an attack on the basic principle that healthcare is a fundamental human right," while Tlaib ripped Schultz for using charitable donations like "a side hustle."

"Your pharmaceutical company makes these so-called charitable donations so you look like you give a shit about sick people," said Tlaib. "But in reality these are just another scheme by your corporation to make money off of sick people."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

Just ONE DAY left in our crucial Mid-Year Campaign and we might not make it without your help.
Who funds our independent journalism? Readers like you who believe in our mission: To inform. To inspire. To ignite change for the common good. No corporate advertisers. No billionaire founder. Our non-partisan, nonprofit media model has only one source of revenue: The people who read and value this work and our mission. That's it.
And the model is simple: If everyone just gives whatever amount they can afford and think is reasonable—$3, $9, $29, or more—we can continue. If not enough do, we go dark.

All the small gifts add up to something otherwise impossible. Please join us today. Donate to Common Dreams. This is crunch time. We need you now.

As US Rolls Back Reproductive Rights, Sierra Leone Moves to Decriminalize Abortion

"I'm hopeful today's announcement gives activists in the U.S., and especially Black women given the shared history, a restored faith that change is possible and progress can be made."

Brett Wilkins ·


'Indefensible': Outrage as New Reporting Shines Light on Biden Deal With McConnell

The president has reportedly agreed to nominate an anti-abortion Republican to a lifetime judgeship. In exchange, McConnell has vowed to stop blocking two Biden picks for term-limited U.S. attorney posts.

Jake Johnson ·


Assange Makes Final Appeal Against US Extradition

"If Julian Assange is not free, neither are we," said a protester at a Friday demonstration against the WikiLeaks founder's impending transfer. "None of us is free."

Brett Wilkins ·


'Payoff for 40 Years of Dark Money': Supreme Court Delivers for Corporate America

"It was the conservative court's larger agenda to gut the regulatory state and decimate executive powers to protect Americans' health and safety," warned one expert.

Jake Johnson ·


NARAL Pro-Choice Endorses Fetterman—Who Vows to End Senate Filibuster to Protect Abortion Rights

"We know we can count on him to boldly fight for abortion rights and access," said the head of one of the nation's largest reproductive rights advocacy groups.

Jon Queally ·

Common Dreams Logo